The 21st Annual Anglonordic Life Science Conference in London will bring together over 400 delegates from leading drug discovery companies, investment firms, and emerging life science startups across Europe. It’s a prime opportunity to connect with industry decision-makers, engage in 1:1 partnering meetings, and gain insights from panel discussions on investment and European technologies.
The event will feature 36 startup pitches, showcasing cutting-edge biotech and medtech companies seeking funding or collaboration. Additionally, the Reception at the London Institute for Healthcare Engineering offers a relaxed setting for networking. With over 80 investment firms attending, this is a key event for anyone looking to expand their presence in the life science sector.
